From: Effect of liberal glucose control on critically ill patients: a systematic review and meta-analysis
Subgroup | Studies | RR (95% CI),P | I2,PHeterogeneity | Pregression |
---|---|---|---|---|
All studies | 7 | 1.32 (1.15, 1.53),<0.001 | 43.7%,0.114 | Â |
Control group target blood glucose | Â | Â | Â | 0.815 |
80–110 mg/dl | 4 | 1.25 (1.11,1.42),<0.001 | 50.6%,0.108 |  |
108–180 mg/dl | 3 | 1.26 (0.73, 2.16),0.405 | 65.1%,0.057 |  |
Diabetes | Â | Â | Â | 0.815 |
Partial diabetic | 4 | 1.25 (1.11,1.42),<0.001 | 50.6%,0.108 | Â |
Diabetic | 3 | 1.26 (0.73, 2.16),0.405 | 65.1%,0.057 | Â |
Study type | Â | Â | Â | 0.815 |
RCT | 4 | 1.25 (1.11,1.42),<0.001 | 50.6%,0.108 | Â |
Non-RCT | 3 | 1.26 (0.73, 2.16),0.405 | 65.1%,0.057 | Â |